Skip to main content
Top
Published in: Head & Neck Oncology 1/2011

Open Access 01-12-2011 | Research

Human papillomavirus genotype distribution in tonsil cancers

Authors: Jean Lacau St Guily, Christine Clavel, Claire Okaïs, Jean-Luc Prétet, Agnès Beby-Defaux, Gérard Agius, Philippe Birembaut, Anne-Carole Jacquard, Yann Léocmach, Benoît Soubeyrand, Didier Riethmuller, François Denis, Christiane Mougin

Published in: Head & Neck Oncology | Issue 1/2011

Login to get access

Abstract

Background

The incidence of tonsil cancers has increased in several countries. French data on HPV prevalence in tonsil cancers are scarce. The objective of this study was thus to assess the overall and type specific HPV prevalence in tonsil histological samples.

Methods

This French retrospective multicenter study involved 12 centres located throughout the country. Were included 185 histological samples collected from year 2000 to 2009 with a validated diagnosis of tonsil invasive carcinomas. HPV prevalence was studied according to gender, age and histological type of cancer.

Results

Overall HPV prevalence was 57% in tonsil cancers. Mean age of diagnosis was comparable in HPV positive tonsils cases (60 ± 11.2) and HPV negative tonsil cases (59 ± 9.6). HPV prevalence was significantly higher in female than in male cases (28/35 versus 78/150 in tonsil cases, respectively, P = 0.003). About 53% of tonsil cases were infected by a single HPV type. Only eight (4%) samples were infected by more than one HPV type. Among HPV positive samples, HPV 16 was found in 89% of tonsil cases. All other HPV types had prevalence below 5%.

Conclusions

Our results indicate that HPV is common in tonsil carcinomas and emphasize the predominant role of HPV 16.
Appendix
Available only for authorised users
Literature
1.
go back to reference Neufcoeur PE, Arafa M, Delvenne P, Saussez S: Involvement of human papillomavirus in upper aero-digestive tracts cancers. Bull Cancer. 2009, 96 (10): 941-50.PubMed Neufcoeur PE, Arafa M, Delvenne P, Saussez S: Involvement of human papillomavirus in upper aero-digestive tracts cancers. Bull Cancer. 2009, 96 (10): 941-50.PubMed
2.
go back to reference Belot A, Grosclaude P, Bossard N, et al: Cancer incidence and mortality in France over the period 1980-2005. Rev Epidemiol Sante Publique. 2008, 56 (3): 159-75. 10.1016/j.respe.2008.03.117.CrossRefPubMed Belot A, Grosclaude P, Bossard N, et al: Cancer incidence and mortality in France over the period 1980-2005. Rev Epidemiol Sante Publique. 2008, 56 (3): 159-75. 10.1016/j.respe.2008.03.117.CrossRefPubMed
3.
go back to reference Marur S, D'Souza G, Westra WH, Forastiere AA: HPV-associated head and neck cancer: a virus-related cancer epidemic. Lancet Oncol. 2010, 11 (8): 781-9. 10.1016/S1470-2045(10)70017-6.CrossRefPubMed Marur S, D'Souza G, Westra WH, Forastiere AA: HPV-associated head and neck cancer: a virus-related cancer epidemic. Lancet Oncol. 2010, 11 (8): 781-9. 10.1016/S1470-2045(10)70017-6.CrossRefPubMed
5.
go back to reference Chaturvedi AK, Engels EA, Anderson WF, Gillison ML: Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol. 2008, 26 (4): 612-9. 10.1200/JCO.2007.14.1713.CrossRefPubMed Chaturvedi AK, Engels EA, Anderson WF, Gillison ML: Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol. 2008, 26 (4): 612-9. 10.1200/JCO.2007.14.1713.CrossRefPubMed
6.
go back to reference Nasman A, Attner P, Hammarstedt L, et al: Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma?. Int J Cancer. 2009, 125 (2): 362-6. 10.1002/ijc.24339.CrossRefPubMed Nasman A, Attner P, Hammarstedt L, et al: Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma?. Int J Cancer. 2009, 125 (2): 362-6. 10.1002/ijc.24339.CrossRefPubMed
7.
go back to reference Hammarstedt L, Lindquist D, Dahlstrand H, et al: Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer. Int J Cancer. 2006, 119 (11): 2620-3. 10.1002/ijc.22177.CrossRefPubMed Hammarstedt L, Lindquist D, Dahlstrand H, et al: Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer. Int J Cancer. 2006, 119 (11): 2620-3. 10.1002/ijc.22177.CrossRefPubMed
8.
go back to reference O'Hanlon S, Forster DP, Lowry RJ: Oral cancer in the North-East of England: incidence, mortality trends and the link with material deprivation. Community Dent Oral Epidemiol. 1997, 25 (5): 371-6.CrossRefPubMed O'Hanlon S, Forster DP, Lowry RJ: Oral cancer in the North-East of England: incidence, mortality trends and the link with material deprivation. Community Dent Oral Epidemiol. 1997, 25 (5): 371-6.CrossRefPubMed
9.
go back to reference Guha N, Boffetta P, Wunsch FV, et al: Oral health and risk of squamous cell carcinoma of the head and neck and esophagus: results of two multicentric case-control studies. Am J Epidemiol. 2007, 166 (10): 1159-73. 10.1093/aje/kwm193.CrossRefPubMed Guha N, Boffetta P, Wunsch FV, et al: Oral health and risk of squamous cell carcinoma of the head and neck and esophagus: results of two multicentric case-control studies. Am J Epidemiol. 2007, 166 (10): 1159-73. 10.1093/aje/kwm193.CrossRefPubMed
10.
go back to reference Ang KK, Harris J, Wheeler R, et al: Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer. N Engl J Med. 2010 Ang KK, Harris J, Wheeler R, et al: Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer. N Engl J Med. 2010
11.
go back to reference Gillison ML, D'Souza G, Westra W, et al: Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst. 2008, 100 (6): 407-20. 10.1093/jnci/djn025.CrossRefPubMed Gillison ML, D'Souza G, Westra W, et al: Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst. 2008, 100 (6): 407-20. 10.1093/jnci/djn025.CrossRefPubMed
12.
go back to reference Kleter B, van Doorn LJ, Schrauwen L, et al: Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus. J Clin Microbiol. 1999, 37 (8): 2508-17.PubMedCentralPubMed Kleter B, van Doorn LJ, Schrauwen L, et al: Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus. J Clin Microbiol. 1999, 37 (8): 2508-17.PubMedCentralPubMed
13.
go back to reference Pretet JL, Jacquard AC, Carcopino X, et al: Human papillomavirus genotype distribution in high grade cervical lesions (CIN 2/3) in France: EDITH study. Int J Cancer. 2008, 122 (2): 424-7. 10.1002/ijc.23093.CrossRefPubMed Pretet JL, Jacquard AC, Carcopino X, et al: Human papillomavirus genotype distribution in high grade cervical lesions (CIN 2/3) in France: EDITH study. Int J Cancer. 2008, 122 (2): 424-7. 10.1002/ijc.23093.CrossRefPubMed
14.
go back to reference Pretet JL, Jacquard AC, Carcopino X, et al: Human papillomavirus (HPV) genotype distribution in invasive cervical cancers in France: EDITH study. Int J Cancer. 2008, 122 (2): 428-32. 10.1002/ijc.23092.CrossRefPubMed Pretet JL, Jacquard AC, Carcopino X, et al: Human papillomavirus (HPV) genotype distribution in invasive cervical cancers in France: EDITH study. Int J Cancer. 2008, 122 (2): 428-32. 10.1002/ijc.23092.CrossRefPubMed
15.
go back to reference Kreimer AR, Clifford GM, Boyle P, Franceschi S: Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev. 2005, 14 (2): 467-75. 10.1158/1055-9965.EPI-04-0551.CrossRefPubMed Kreimer AR, Clifford GM, Boyle P, Franceschi S: Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev. 2005, 14 (2): 467-75. 10.1158/1055-9965.EPI-04-0551.CrossRefPubMed
17.
go back to reference Hannisdal K, Schjolberg A, De Angelis PM, Boysen M, Clausen OP: Human papillomavirus (HPV)-positive tonsillar carcinomas are frequent and have a favourable prognosis in males in Norway. Acta Otolaryngol. 2010, 130 (2): 293-9. 10.3109/00016480903071377.CrossRefPubMed Hannisdal K, Schjolberg A, De Angelis PM, Boysen M, Clausen OP: Human papillomavirus (HPV)-positive tonsillar carcinomas are frequent and have a favourable prognosis in males in Norway. Acta Otolaryngol. 2010, 130 (2): 293-9. 10.3109/00016480903071377.CrossRefPubMed
18.
go back to reference Mellin H, Friesland S, Lewensohn R, Dalianis T, Munck-Wikland E: Human papillomavirus (HPV) DNA in tonsillar cancer: clinical correlates, risk of relapse, and survival. Int J Cancer. 2000, 89 (3): 300-4. 10.1002/1097-0215(20000520)89:3<300::AID-IJC14>3.0.CO;2-G.CrossRefPubMed Mellin H, Friesland S, Lewensohn R, Dalianis T, Munck-Wikland E: Human papillomavirus (HPV) DNA in tonsillar cancer: clinical correlates, risk of relapse, and survival. Int J Cancer. 2000, 89 (3): 300-4. 10.1002/1097-0215(20000520)89:3<300::AID-IJC14>3.0.CO;2-G.CrossRefPubMed
19.
go back to reference Strome SE, Savva A, Brissett AE, et al: Squamous cell carcinoma of the tonsils: a molecular analysis of HPV associations. Clin Cancer Res. 2002, 8 (4): 1093-100.PubMed Strome SE, Savva A, Brissett AE, et al: Squamous cell carcinoma of the tonsils: a molecular analysis of HPV associations. Clin Cancer Res. 2002, 8 (4): 1093-100.PubMed
20.
go back to reference Li W, Thompson CH, Xin DA, et al: bsence of human papillomavirus in tonsillar squamous cell carcinomas from Chinese patients. Am J Pathol. 2003, 163 (6): 2185-9. 10.1016/S0002-9440(10)63576-6.PubMedCentralCrossRefPubMed Li W, Thompson CH, Xin DA, et al: bsence of human papillomavirus in tonsillar squamous cell carcinomas from Chinese patients. Am J Pathol. 2003, 163 (6): 2185-9. 10.1016/S0002-9440(10)63576-6.PubMedCentralCrossRefPubMed
21.
go back to reference Li W, Thompson CH, O'Brien CJ, et al: Human papillomavirus positivity predicts favourable outcome for squamous carcinoma of the tonsil. Int J Cancer. 2003, 106 (4): 553-8. 10.1002/ijc.11261.CrossRefPubMed Li W, Thompson CH, O'Brien CJ, et al: Human papillomavirus positivity predicts favourable outcome for squamous carcinoma of the tonsil. Int J Cancer. 2003, 106 (4): 553-8. 10.1002/ijc.11261.CrossRefPubMed
22.
go back to reference Chien CY, Su CY, Fang FM, et al: Lower prevalence but favorable survival for human papillomavirus-related squamous cell carcinoma of tonsil in Taiwan. Oral Oncol. 2008, 44 (2): 174-9. 10.1016/j.oraloncology.2007.01.018.CrossRefPubMed Chien CY, Su CY, Fang FM, et al: Lower prevalence but favorable survival for human papillomavirus-related squamous cell carcinoma of tonsil in Taiwan. Oral Oncol. 2008, 44 (2): 174-9. 10.1016/j.oraloncology.2007.01.018.CrossRefPubMed
23.
go back to reference Hobbs CG, Sterne JA, Bailey M, Heyderman RS, Birchall MA, Thomas SJ: Human papillomavirus and head and neck cancer: a systematic review and meta-analysis. Clin Otolaryngol. 2006, 31 (4): 259-66. 10.1111/j.1749-4486.2006.01246.x.CrossRefPubMed Hobbs CG, Sterne JA, Bailey M, Heyderman RS, Birchall MA, Thomas SJ: Human papillomavirus and head and neck cancer: a systematic review and meta-analysis. Clin Otolaryngol. 2006, 31 (4): 259-66. 10.1111/j.1749-4486.2006.01246.x.CrossRefPubMed
24.
go back to reference Berrino F, Merletti F, Zubiri A, et al: A comparative study of smoking, drinking and dietary habits in population samples in France, Italy, Spain and Switzerland. II. Tobacco smoking. Rev Epidemiol Sante Publique. 1988, 36 (3): 166-76.PubMed Berrino F, Merletti F, Zubiri A, et al: A comparative study of smoking, drinking and dietary habits in population samples in France, Italy, Spain and Switzerland. II. Tobacco smoking. Rev Epidemiol Sante Publique. 1988, 36 (3): 166-76.PubMed
Metadata
Title
Human papillomavirus genotype distribution in tonsil cancers
Authors
Jean Lacau St Guily
Christine Clavel
Claire Okaïs
Jean-Luc Prétet
Agnès Beby-Defaux
Gérard Agius
Philippe Birembaut
Anne-Carole Jacquard
Yann Léocmach
Benoît Soubeyrand
Didier Riethmuller
François Denis
Christiane Mougin
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Head & Neck Oncology / Issue 1/2011
Electronic ISSN: 1758-3284
DOI
https://doi.org/10.1186/1758-3284-3-6

Other articles of this Issue 1/2011

Head & Neck Oncology 1/2011 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine